Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01556230 · ClinicalTrials.gov registry record
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
A clinical trial of Pituitary Adenoma and Pituitary Tumor, sponsored by Columbia University.
- Completed
- Registry status
- 292
- Enrollment target
- 1
- Study location
NCT01556230 is a study of Pituitary Adenoma and Pituitary Tumor that has completed, run by Columbia University. The registered enrollment target is 292 participants, above the 256-participant average among 9 other Pituitary Adenoma trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01556230, a study of Pituitary Adenoma and Pituitary Tumor, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 292 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is the first comprehensive prospective study of clinically non-functioning pituitary adenomas (CNFAs). Two groups of subjects will be studied: Group I will consist of 100 patients with clinically non-functioning (CNF) pituitary lesions who are asymptomatic and do not require surgery; Group II will consist of 250 patients who have pituitary lesions that are symptomatic and require surgery. Patients will be followed with a series of endocrine laboratory testing, physical examinations, testing of quality of life and neurocognitive function before and serially over time either during non-surgical management or after surgery and in some patients before and after radiotherapy (RT). Data on pituitary magnetic resonance imaging (MRI) studies and visual field testing being done over time during follow up as part of clinical care will be collected.
Conditions Studied
Interventions
- PROCEDURE Surgical intervention for CNFA
- RADIATION Radiotherapy for CNFA
Study Locations (1)
New York
- Columbia University Vagelos College of Physicians & Surgeons - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2010-11 |
| Est. Completion | 2024-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01556230
The ClinicalTrials.gov registry entry for NCT01556230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 256-participant average among 9 other Pituitary Adenoma trials with a reported enrollment target (14% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pituitary Adenoma appearing as the primary indexed condition, and to 2 interventions - of which Surgical intervention for CNFA is the first listed.
NCT01556230 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01556230 about?
NCT01556230 is a clinical study titled "Prospective Study of Clinically Nonfunctioning Pituitary Adenomas". This project is the first comprehensive prospective study of clinically non-functioning pituitary adenomas (CNFAs). Two groups of subjects will be studied: Group I will consist of 100 patients with clinically non-functioning (CNF) pituitary lesions who are asymptomatic and do not require surgery; Gr...
What is the current status of trial NCT01556230?
This trial is currently completed. The enrollment target is 292 participants. The study started on 2010-11. Estimated completion is 2024-06.
What conditions does trial NCT01556230 study?
This clinical trial studies the following conditions: Pituitary Adenoma, Pituitary Tumor.
What interventions are being tested in trial NCT01556230?
The interventions under investigation include: Surgical intervention for CNFA (PROCEDURE), Radiotherapy for CNFA (RADIATION).
Who is sponsoring clinical trial NCT01556230?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01556230 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pituitary Adenoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
RECRUITING · Phase 4
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
RECRUITING
-
DDAVP for Pituitary Adenoma
RECRUITING · NA
-
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RECRUITING · Phase 4
-
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
RECRUITING · Phase 1
-
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.